2024/01 Japan: a survey on current clinical trials for cell medicines and cell sheets
In a recent article in Nikkei Biotech, the state of
2ß23/12 Kao introduces gallic acid made by synthetic biology
https://bio.nikkeibp.co.jp/atcl/news/p1/23/12/13/11409/ On December 13, 2023, Kao announced that it will
NEDO consortium pioneers ground improvement with CO2-fixed cement
https://www.nedo.go.jp/news/press/AA5_101721.html In Japan, approximately 8 million tons or approximately 20%
Nikkei Biotech publishes 2024 “sumo ranking” of Japanese pharma
https://bio.nikkeibp.co.jp/atcl/report/16/082400017/012500075/ According to this analysis, the strongest companies (“Ozeki”) in
Cultured meat from pluripotent fat cells: Ebara
https://bio.nikkeibp.co.jp/atcl/news/p1/24/01/17/11509/ Nihon University and Ebara Corporation study pluripotent cells made
Silk Strand Pharma uses silkworms for the preclinical testing of new antibiotics
https://bio.nikkeibp.co.jp/atcl/column/16/021500017/012300318/ Silk Strand Pharma, a startup in Tokyo that develops
Consortium achieves manufacture of “carbon negative” tetrapods for wave dissipation
https://www.nedo.go.jp/news/press/AA5_101715.html A consortium from Kajima, Denka and Takenaka Corporation, under
iPS cell technology may replace animal tests in some drug screening
https://bio.nikkeibp.co.jp/atcl/news/p1/24/01/22/11525/ A research group led by Professor Masato Fujioka and
Japan: a survey on current clinical trials for cell medicines and cell sheets
In a recent article in Nikkei Biotech, the state of
Most Popular Posts
Archives
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- September 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- October 2011
- May 2011
- April 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- August 2010
- July 1993
- April 1993
- October 1991
- January 1991
- October 1986